More NewsRead More
KaloBios Announces Retirement of David W. Pritchard, President and Chief Executive Officer
January 08, 2015
KaloBios Reports Top-Line Data for Phase 2 Study of KB001-A to Treat Pseudomonas Aeruginosa Lung Infections in Cystic Fibrosis Patients
January 06, 2015
Publication by KaloBios and Collaborators Shows EphA3 as Target for Highly Selective Anticancer Therapy
August 14, 2014
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here